Vaccines Market Size, Share, Industry Trends and Forecast to 2033
This report delves into the global vaccines market, providing insights into market size, trends, and forecasts from 2023 to 2033. It covers key segments, regional analyses, and technological advancements that shape the industry.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $52.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $103.19 Billion |
| Top Companies | Pfizer, Moderna, Sanofi, GlaxoSmithKline, Johnson & Johnson |
| Last Modified Date | 15 Nov 2024 |
Vaccines Market Report (2023 - 2033)
Vaccines Market Overview
What is the Market Size & CAGR of Vaccines market in 2023?
Vaccines Industry Analysis
Vaccines Market Segmentation and Scope
Request a custom research report for industry.
Vaccines Market Analysis Report by Region
Europe Vaccines Market Report:
Europe’s market is valued at USD 15.73 billion in 2023, projected to double to USD 30.91 billion by 2033, as regulatory support for vaccine development continues and new immunization technologies emerge.Asia Pacific Vaccines Market Report:
The Asia Pacific region is estimated to account for USD 10.66 billion in 2023, projected to grow to USD 20.95 billion by 2033, driven by increasing healthcare investments, government immunization programs, and rising disease outbreaks.North America Vaccines Market Report:
In North America, the market stands at USD 17.10 billion in 2023, anticipated to grow to USD 33.61 billion by 2033, bolstered by established health systems, innovation in vaccine technologies, and substantial government funding.South America Vaccines Market Report:
In South America, the vaccines market will reach approximately USD 3.27 billion in 2023, expected to grow to USD 6.43 billion by 2033, fostered by improving healthcare infrastructure and educational campaigns on vaccination.Middle East & Africa Vaccines Market Report:
The Middle East and Africa market is valued at USD 5.74 billion in 2023, expected to expand to USD 11.29 billion by 2033, with increasing public health initiatives and international collaborations to enhance immunization rates.Request a custom research report for industry.
Vaccines Market Analysis By Vaccine Type
Global Vaccines Market, By Vaccine Type Market Analysis (2023 - 2033)
In the vaccines market, pediatric vaccines dominate, valued at USD 31.59 billion in 2023 and expected to reach USD 62.10 billion by 2033, capturing about 60% of the market share. Adult vaccines follow with a size of USD 10.73 billion in 2023, growing to USD 21.08 billion by 2033. Travelers' vaccines, primarily for international travel requirements, are also significant, valued at USD 10.18 billion in 2023 with expectations of reaching USD 20.01 billion by 2033.
Vaccines Market Analysis By Administration Route
Global Vaccines Market, By Administration Route Market Analysis (2023 - 2033)
The administration routes of vaccines further segment the market, with intramuscular injections leading at USD 29.73 billion in 2023, expected to double to USD 58.43 billion by 2033. Subcutaneous and oral routes lag behind due to lower uptake, valued at USD 12.71 billion and USD 5.09 billion respectively in 2023, growing to USD 24.97 billion and USD 10.01 billion by 2033.
Vaccines Market Analysis By End User
Global Vaccines Market, By End-User Market Analysis (2023 - 2033)
Hospital pharmacies are the primary distribution channel for vaccines, valued at USD 29.73 billion in 2023, with revenue surging to USD 58.43 billion by 2033. Retail pharmacies and online pharmacies are also gaining traction due to increased consumer access and preference, with market sizes expected to rise from USD 12.71 billion and USD 5.09 billion, respectively, to USD 24.97 billion and USD 10.01 billion by 2033.
Vaccines Market Analysis By Distribution Channel
Global Vaccines Market, By Distribution Channel Market Analysis (2023 - 2033)
The distribution channels of the vaccines market highlight vital access points: hospital pharmacies dominate with a 56.63% market share in 2023, extending to 56.63% by 2033. Retail and online pharmacies are anticipated to grow significantly, with shares at 24.2% and 9.7% respectively in 2023, sustaining similar shares by 2033 as consumer behavior shifts towards convenience.
Vaccines Market Analysis By Technology
Global Vaccines Market, By Technology Market Analysis (2023 - 2033)
Technological advancements play a vital role in the vaccines market. Traditional technologies still hold a substantial market share valued at USD 31.59 billion in 2023, growing to USD 62.10 billion by 2033. Novel and mRNA technologies show promising growth; however, they currently represent smaller segments, set to expand from USD 10.73 billion and USD 4.97 billion in 2023 to USD 21.08 billion and USD 9.77 billion by 2033, respectively.
Vaccines Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Vaccines Industry
Pfizer:
Pfizer is a leading global biopharmaceutical company with a robust portfolio in vaccine development, including the highly regarded COVID-19 mRNA vaccine, which has transformed vaccine delivery.Moderna:
Moderna has pioneered mRNA vaccine technology, leading with its COVID-19 vaccine and focusing on emerging infectious diseases and personalized vaccines.Sanofi:
Sanofi specializes in a diverse range of vaccine solutions, emphasizing preventative care against infectious diseases with a strong market presence.GlaxoSmithKline:
GSK is known for its extensive vaccine offerings, with a commitment to public health and innovative methods to increase vaccine uptake.Johnson & Johnson:
J&J has a broad vaccine portfolio and a notable contribution to COVID-19 vaccine distribution globally, focusing on improving accessibility and efficacy.We're grateful to work with incredible clients.
